Ipilimumab-induced hypophysitis and uveitis in a patient with metastatic melanoma and a history of ipilimumab-induced skin rash.

Nallapaneni, Neelima N; Mourya, Rajesh; Bhatt, Vijaya Raj; Malhotra, Sakshi; Ganti, Apar Kishor; Tendulkar, Ketki K

Nallapaneni, Neelima N; Mourya, Rajesh; Bhatt, Vijaya Raj; Malhotra, Sakshi; Ganti, Apar Kishor; Tendulkar, Ketki K.

Afiliação

Nallapaneni NN; From the University of Nebraska Medical Center, Department of Internal Medicine, Division of Nephrology; Creighton University Medical Center, Department of Internal Medicine; University of Nebraska Medical Center, Department of Internal Medicine, Division of Hematology and Oncology; VA Nebraska-West
Mourya R; From the University of Nebraska Medical Center, Department of Internal Medicine, Division of Nephrology; Creighton University Medical Center, Department of Internal Medicine; University of Nebraska Medical Center, Department of Internal Medicine, Division of Hematology and Oncology; VA Nebraska-West
Bhatt VR; From the University of Nebraska Medical Center, Department of Internal Medicine, Division of Nephrology; Creighton University Medical Center, Department of Internal Medicine; University of Nebraska Medical Center, Department of Internal Medicine, Division of Hematology and Oncology; VA Nebraska-West
Malhotra S; From the University of Nebraska Medical Center, Department of Internal Medicine, Division of Nephrology; Creighton University Medical Center, Department of Internal Medicine; University of Nebraska Medical Center, Department of Internal Medicine, Division of Hematology and Oncology; VA Nebraska-West
Ganti AK; From the University of Nebraska Medical Center, Department of Internal Medicine, Division of Nephrology; Creighton University Medical Center, Department of Internal Medicine; University of Nebraska Medical Center, Department of Internal Medicine, Division of Hematology and Oncology; VA Nebraska-West
Tendulkar KK; From the University of Nebraska Medical Center, Department of Internal Medicine, Division of Nephrology; Creighton University Medical Center, Department of Internal Medicine; University of Nebraska Medical Center, Department of Internal Medicine, Division of Hematology and Oncology; VA Nebraska-West

J Natl Compr Canc Netw ; 12(8): 1077-81, 2014 Aug.

Article em En | MEDLINE | ID: mdl-25099440

Assuntos

Anticorpos Monoclonais/efeitos adversos; Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos/patologia; Exantema/patologia; Melanoma/tratamento farmacológico; Anticorpos Monoclonais/administração & dosagem; Antígeno CTLA-4/antagonistas & inibidores; Antígeno CTLA-4/imunologia; Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos/imunologia; Exantema/induzido quimicamente; Exantema/imunologia; Humanos; Ipilimumab; Masculino; Melanoma/complicações; Melanoma/patologia; Pessoa de Meia-Idade; Doenças da Hipófise/induzido quimicamente; Doenças da Hipófise/patologia; Uveíte/induzido quimicamente; Uveíte/patologia

Buscar no Google

Imprimir

XML

PubMed Links

Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos / Exantema / Melanoma / Anticorpos Monoclonais Limite: Humans / Male / Middle aged Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Buscar no Google

Imprimir

XML

PubMed Links